Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Multiregional brain iron deficiency in restless legs syndrome.

Godau J, Klose U, Di Santo A, Schweitzer K, Berg D.

Mov Disord. 2008 Jun 15;23(8):1184-7. doi: 10.1002/mds.22070.

PMID:
18442125
2.

MRI-determined regional brain iron concentrations in early- and late-onset restless legs syndrome.

Earley CJ, B Barker P, Horsk√° A, Allen RP.

Sleep Med. 2006 Aug;7(5):458-61. Epub 2006 Jun 5.

PMID:
16740411
3.

Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.

Connor JR, Boyer PJ, Menzies SL, Dellinger B, Allen RP, Ondo WG, Earley CJ.

Neurology. 2003 Aug 12;61(3):304-9.

PMID:
12913188
4.

T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome.

Astrakas LG, Konitsiotis S, Margariti P, Tsouli S, Tzarouhi L, Argyropoulou MI.

Neurology. 2008 Sep 16;71(12):911-6. doi: 10.1212/01.wnl.0000325914.50764.a2.

PMID:
18794493
5.

Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome.

Connor JR, Wang XS, Patton SM, Menzies SL, Troncoso JC, Earley CJ, Allen RP.

Neurology. 2004 May 11;62(9):1563-7.

PMID:
15136682
6.

The treatment of restless legs syndrome with intravenous iron dextran.

Earley CJ, Heckler D, Allen RP.

Sleep Med. 2004 May;5(3):231-5. Erratum in: Sleep Med. 2004 Nov;5(6):613.

PMID:
15165528
7.

Low brain iron content in idiopathic restless legs syndrome patients detected by phase imaging.

Rizzo G, Manners D, Testa C, Tonon C, Vetrugno R, Marconi S, Plazzi G, Pizza F, Provini F, Malucelli E, Gramegna LL, Lodi R.

Mov Disord. 2013 Nov;28(13):1886-90. doi: 10.1002/mds.25576. Epub 2013 Jun 18.

PMID:
23780623
8.

Is ferroportin-hepcidin signaling altered in restless legs syndrome?

Clardy SL, Wang X, Boyer PJ, Earley CJ, Allen RP, Connor JR.

J Neurol Sci. 2006 Sep 25;247(2):173-9. Epub 2006 Jun 8.

PMID:
16759669
9.

Association between low serum ferritin and restless legs syndrome in patients with attention deficit hyperactivity disorder.

Oner P, Dirik EB, Taner Y, Caykoylu A, Anlar O.

Tohoku J Exp Med. 2007 Nov;213(3):269-76.

10.

Substantia nigra hypoechogenicity: definition and findings in restless legs syndrome.

Godau J, Schweitzer KJ, Liepelt I, Gerloff C, Berg D.

Mov Disord. 2007 Jan 15;22(2):187-92.

PMID:
17133515
11.

Mitochondrial ferritin in the substantia nigra in restless legs syndrome.

Snyder AM, Wang X, Patton SM, Arosio P, Levi S, Earley CJ, Allen RP, Connor JR.

J Neuropathol Exp Neurol. 2009 Nov;68(11):1193-9. doi: 10.1097/NEN.0b013e3181bdc44f.

12.

Thy1 expression in the brain is affected by iron and is decreased in Restless Legs Syndrome.

Wang X, Wiesinger J, Beard J, Felt B, Menzies S, Earley C, Allen R, Connor J.

J Neurol Sci. 2004 May 15;220(1-2):59-66.

PMID:
15140607
13.

Opioids protect against substantia nigra cell degeneration under conditions of iron deprivation: a mechanism of possible relevance to the Restless Legs Syndrome (RLS) and Parkinson's disease.

Sun YM, Hoang T, Neubauer JA, Walters AS.

J Neurol Sci. 2011 May 15;304(1-2):93-101. doi: 10.1016/j.jns.2011.02.003. Epub 2011 Mar 3.

PMID:
21376342
14.

MRI measurement of brain iron in patients with restless legs syndrome.

Allen RP, Barker PB, Wehrl FW, Song HK, Earley CJ.

Neurology. 2001 Jan 23;56(2):263-5. Erratum in: Neurology. 2015 Jan 6;84(1):105. Wehrl, F [corrected to Wehrl, F W].

PMID:
11160969
15.

Severity of restless legs syndrome is inversely correlated with echogenicity of the substantia nigra in different neurodegenerative movement disorders. a preliminary observation.

Pedroso JL, Bor-Seng-Shu E, Felicio AC, Braga-Neto P, Dutra LA, de Aquino CC, Ferraz HB, do Prado GF, Teixeira MJ, Barsottini OG.

J Neurol Sci. 2012 Aug 15;319(1-2):59-62. doi: 10.1016/j.jns.2012.05.015. Epub 2012 May 24.

PMID:
22632781
16.

Iron metabolism and the risk of restless legs syndrome in an elderly general population--the MEMO-Study.

Berger K, von Eckardstein A, Trenkwalder C, Rothdach A, Junker R, Weiland SK.

J Neurol. 2002 Sep;249(9):1195-9.

PMID:
12242538
17.

Increased iron-related MRI contrast in the substantia nigra in Parkinson's disease.

Gorell JM, Ordidge RJ, Brown GG, Deniau JC, Buderer NM, Helpern JA.

Neurology. 1995 Jun;45(6):1138-43. Erratum in: Neurology 1995 Jul;45(7):1420.

PMID:
7783878
18.

Iron status and restless legs syndrome in the elderly.

O'Keeffe ST, Gavin K, Lavan JN.

Age Ageing. 1994 May;23(3):200-3.

PMID:
8085504
19.

Attention-deficit/hyperactivity disorder, Tourette's syndrome, and restless legs syndrome: the iron hypothesis.

Cortese S, Lecendreux M, Bernardina BD, Mouren MC, Sbarbati A, Konofal E.

Med Hypotheses. 2008;70(6):1128-32. doi: 10.1016/j.mehy.2007.10.013. Epub 2007 Dec 27.

PMID:
18164140
20.

Restless legs syndrome and low brain iron levels in patients with haemochromatosis.

Haba-Rubio J, Staner L, Petiau C, Erb G, Schunck T, Macher JP.

J Neurol Neurosurg Psychiatry. 2005 Jul;76(7):1009-10.

Supplemental Content

Support Center